| | |
| Clinical data | |
|---|---|
| Other names | Androst-5-ene-3,17-dione; Δ5-Androstenedione; NSC-12873 |
| Routes of administration | Oral |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| ChEBI | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C19H26O2 |
| Molar mass | 286.415 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
5-Androstenedione, also known as androst-5-ene-3,17-dione, is a prohormone of testosterone. The World Anti-Doping Agency prohibits its use in athletes. In the United States, it is a controlled substance.
5-Androstenedione is structurally similar to 4-androstenedione, with the exception of the position of a carbon-carbon double bond.
4-Androstenedione is naturally produced in the body by the adrenal glands and gonads. In addition to testosterone, it is also a precursor of estrone and estradiol. [1] [2]
5-Androstenedione is on the World Anti-Doping Agency's list of prohibited substances, [3] and is therefore banned from use in most major sports.